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ABSTRACT 
Background  The genetic basis of 2 distinct forms of atrichia with papules has recently been defined 
at the molecular level. In atrichia with papular lesions (APL; Online Mendelian Inheritance in Man 
[OMIM] 209500), mutations in the hairless gene on chromosome 8p21 have recently been 
identified. Atrichia with papules also occurs in the clinical setting of vitamin D–dependent rickets 
type IIA (VDDR IIA; OMIM 277440), resulting from mutations in the vitamin D receptor gene on 
chromosome 12q12-q14. Despite the distinct genetic basis for both forms of atrichia, the 
clinical findings are strikingly similar and exhibit classic pathognomonic features unique to this 
phenotype. We sought to document the clinical and molecular features of APL and VDDR IIA. 
Observations  Molecular analysis of the hairless and vitamin D receptor genes was performed on 
genomic DNA from probands and family members from 3 families with APL and 2 with 
VDDRIIA. We present a clinical and histologic comparison of atrichia in patients with APL and 
VDDR IIA and highlight the genetically heterogeneous basis of atrichia by identification of 
pathogenetic mutations. 
Conclusions  Increased awareness of these diseases will allow early diagnosis and potential 
therapeutic intervention for the rickets in VDDR IIA and avoidance of treatment of the atrichia in 
both APL and VDDR IIA. Their phenotype similarities suggest the possibility of a functional 
relationship between HR and VDR. 
INTRODUCTION 
The terms alopecia, hypotrichosis, and atrichia are frequently used interchangeably in the literature. 
However, their strict definitions are quite distinct. Alopecia can be defined as thenoncongenital 
process of hair loss, which may progress to partial or complete baldness. These forms of pattern 
alopecia may be permanent or reversible, whereas hypotrichosis is a term meaning the diffuse 
(congenital or acquired) forms of extensive hair loss leading to paucity of hair.1 
In contrast, the term atrichia is reserved for the most dramatic and severe forms of hair loss, in 
particular, those that are characterized by an absence of hair follicles. Atrichia is manifested by 
congenital or early-onset hair loss, which ends rapidly in a completely smooth bald scalp.1 These 
conditions are extremely rare, and, in fact, only very few disorders typified by absence of hair (and 
hair follicles) have been described. Two such conditions are atrichia with papular lesions2-4 (APL; 
Online Mendelian Inheritance in Man [OMIM] 209500) and atrichia in the setting of vitamin D–
dependent rickets or rickets-alopecia syndrome5-6 (VDDR IIA; OMIM 277440). 
In APL, a rare autosomal recessive disease characterized by early onset of atrichia followed by a 
papular eruption, mutations in the hairless gene (HR) on chromosome 8p21 have recently been 
identified. 7-18 Atrichia also occurs in the clinical setting of VDDR IIA due to mutations in the 
vitamin D receptor gene (VDR) on chromosome 12q12-q14.5-6 Patients with recessively inherited 
mutations in the VDR gene (vitamin D–dependent rickets type II, VDDR II, OMIM 277440) 
display several phenotypic characteristics that can be attributed to defective mineral metabolism, 
including hypocalcemia, hyperparathyroidism, rickets, and osteomalacia.5-6,19-21 Each of these 
features is also observed in patients with dietary vitamin D deficiency or in patients with vitamin D-
dependent rickets type I (VDDR I), who have 25-hydroxyvitamin D 1  hydroxylase deficiency. 
Complete early-onset atrichia is a feature of only a subset of patients with VDDR II, therefore 
designated VDDR IIA. 
Despite the distinct genetic basis for both forms of atrichia, the clinical findings are strikingly 
similar and exhibit features unique to this phenotype. In this study, we document a detailed clinical 
and histopathologic comparison of the progression of atrichia in patients with APL and VDDR IIA. 
Furthermore, we underscore the genetically heterogeneous basis of atrichia by identification of 
several pathogenetic mutations. Increased awareness of these diseases will allow early diagnosis 
and adequate therapeutic intervention for the rickets in VDDR IIA and, importantly, the avoidance 
of treatment of the atrichia in APL and VDDR IIA. 
METHODS 
HUMAN SUBJECTS 
Three families with APL (families 1, 2, and 3) and 2 with VDDR IIA (families 4 and 5) were 
studied. Genomic DNA was isolated from peripheral blood collected in edetic acid (EDTA)–
containing tubes according to standard techniques.22 All samples were collected after informed 
consent and in accordance with the rules of the local institutional review board. 
MOLECULAR ANALYSIS OF THE HR AND VDR GENES 
To search for mutations in the human HR and VDR genes, all exons and splice junctions were 
amplified via polymerase chain reaction from genomic DNA and sequenced directly in an ABI 
Prism 310 Automated Sequencer, using the ABI Prism Big Dye Terminator Cycle Sequencing 
Ready Reaction Kit (PE Applied Biosystems, Foster City, Calif) following purification in 
Centriflex Gel Filtration Cartridges (Edge Biosystems, Gaithersburg, Md) as described 
previously.10, 21 The mutations were identified by visual inspection and comparison with control 
sequences generated from unrelated, unaffected individuals. 
HISTOPATHOLOGIC ANALYSIS 
Biopsies were performed in the third proband of the VDDR IIA family 4 to confirm the diagnosis of 
atrichia. Specifically, two 3-mm punch biopsy specimens were taken from the left parietal region of 
the scalp and the arm under local anesthesia. The samples were fixed in 4% paraformaldehyde and 
embedded in paraffin. The 4-µm sections were processed and stained with hematoxylin-eosin 
according  to standard protocols. 
RESULTS 
CLINICAL FINDINGS IN APL 
Family 1 
The proband in family 1 was a 21-year-old Jewish Israeli woman, the only affected daughter of 
first-cousin parents (Figure 1A, C, and E). She was born with hair, most of which she shed 
within the first 3 days of life, and which she completely lost by age 7 months. The progression of 
hair loss was from front to back, while the last hairs remained on the posterior vertex of the scalp. 
The hair never regrew, except for a few waxing and waning hairs in the eyebrows. Papules started 
to appear at age 4 years, and are now more pronounced on the elbows and knees. The 
proband's medical history is significant only for hyperthyroidism since age 10 years. However, 
dysregulated thyroid status seems to be unrelated to APL in this family, since her father and 
older brother have hypothyroidism, and her younger sister has borderline hyperthyroidism. 
On physical examination, complete scalp atrichia and sparse eyebrows and eyelashes were noted. 
The scalp showed only a few papular lesions, mainly on the posterior aspect. The papules were 
more prominent under and mainly lateral to the eyes. Many papules were noted on the arms and 
around the elbows, on the thighs and around the knees. The papules around the elbows and knees 
were notably larger than on other body sites. 
Family 2 
The proband in family 2 was a 13-year-old boy, the only affected son of his first-cousin Arab-Israeli 
parents. He was born with hair, but it was completely shed by age 1 year. Papules started to appear 
on the face and knees at age 11 years. Complete scalp atrichia and an almost complete lack of 
eyebrows and eyelashes with no bodily hair were noted on physical examination. Papules were 
found on the cheeks, above and below the eyes, on the arms, forearms, and around the elbows, on 
the ear, chest, abdomen, thighs, and around the knees. 
Family 3 
The proband in family 3 was a 2-year-old girl, the only affected daughter of her first-cousin Arab-
Palestinian parents. She was born with hair, but it was almost completely shed by age 1 year. The 
progress of hair loss occurred in a frontal to posterior direction. Complete scalp atrichia, with only 
few hairs left on the vertex, and an almost complete lack of eyebrows and eyelashes were noted on 
physical examination. Only few papules were found on the scalp and face. 
CLINICAL FINDINGS IN VDDR IIA 
Family 4 
We present in family 4 the clinical history of 4 probands from a large family with VDDR IIA. The 
first and second probands were dizygotic twin girls, age 3 years, both affected with VDDR IIA, and 
born to first-cousin Arab-Israeli parents (Figure 1B). They were born with only a few fine scalp 
hairs that started to fall out by age 2 months and were completely shed within the subsequent 2 to 4 
months. Notably, the progression of the hair loss occurred in a frontal to posterior wave. Papules 
began to appear on the scalp, face, and knees at age 2 years. 
On examination, we noted only 6 scalp hairs and sparse eyelashes and eyebrows. Papules in one of 
the twins numbered approximately 80 and were distributed on the posterior scalp, forehead, 
arms, forearms, thighs, and shins. Papules in the other twin numbered approximately 15 and were 
distributed on the posterior scalp, cheeks (lateral to the eye), and arms. 
The third patient was a 25-year-old man born with hair that shed from age 1 month to age 12 
months. On examination, we noted complete atrichia, sparse eyebrows, normal eyelashes, and a few 
hairs on his mustache. Papules were present mainly on the lateral cheeks, neck, back, elbows, arms, 
forearms, buttocks, knees (Figure 1 F), thighs, and shins. Notably, papules around the elbows were 
larger in size, and there was obvious pitting and regression of papules mainly below the knees and 
around the elbows. 
The fourth patient in family 4 was a 13-year-old boy born with hair that began to shed immediately 
after birth; he became atrichic within 3 months. The hair fell out in a frontal to posterior direction. 
On examination, we observed approximately 50 hairs on the top posterior scalp along with a few 
hypopigmented marks. The eyebrows were sparse, but the eyelashes were almost 
completely normal. Papules were found lateral to the eyes and on the cheeks, lateral to the nose, on 
the arms and forearms, around the elbows, back, neck, thighs, and shins, and large papules around 
the knees. 
Family 5 
The proband in family 5 was a 47-year-old man, the only affected son of Italian parents with no 
known consanguinity (Figure 1D). He had hair at birth, which was shed by age 2 months. 
Facial cysts were first noticed during his teen years and progressively increased. He had from 
rickets since age 18 months. 
Complete scalp atrichia, almost complete lack of eyebrows, sparse hairs on the upper lip, between 
the lower lip and chin, and inside the ears, and no bodily hair were noted on physical 
examination. The eyelashes were essentially normal. Papules were found on the cheeks, above and 
below the eyes, arms, forearms, around the elbows, on the ear, chest, abdomen, thighs, and around 
the knees. Numerous yellow to white papules measuring 3 to 8 mm were found on the face, 
especially lateral to the eyes, and on the forehead and cheeks. Smaller papules were also found on 
the forearms, thighs, and legs. 
HISTOPATHOLOGIC ANALYSIS OF SCALP SKIN IN FAMILY 4 
A skin biopsy specimen was taken from the shoulder and scalp of the third proband (25-year-old 
man) in VDDR IIA family 4. Analysis revealed several features similar to APL, including the 
presence of only a few abnormal follicles represented by the remaining parts of the upper portion, 
including the hair canal and sebaceous gland, and a large keratinous cyst with a thin epithelium 
filled with lamellated keratin masses. 
MUTATIONS IN THE HR GENE IN APL 
Family 1 
Direct sequence analysis of each exon of the HR gene in the proband revealed a homozygous 
frameshift 11–base pair (bp) deletion in exon 2, designated 177del11, which resulted in a premature 
termination codon 183 bp downstream (Figure 2). The parents were both heterozygous carriers, 
whereas the proband's older unaffected brother was genotypically normal. 
Families 2 and 3 
The probands in families 2 and 3 were both homozygous for a previously identified 1-bp deletion in 
exon 9, designated as 2147delC, leading to a frameshift and premature termination codon 554 bp 
downstream in exon 12. This mutation has been described in several families of Arab-Palestinian 
origin.9 
MUTATIONS IN THE VDR GENE IN VDDR IIA 
Family 4 
The genetic basis of VDDR IIA in family 4 has been previously described in detail.21, 23 The 
affected individuals in family 4 were homozygous for a nonsense mutation (Y292X) in the ligand-
binding domain of VDR, which was shown to result in the complete loss of functional messenger 
RNA (mRNA) encoding the VDR protein.21, 23 
Family 5 
Molecular analysis of the VDR gene in the proband of family 5 revealed a homozygous nonsense 
mutation, designated R30X, within the first zinc finger of the DNA-binding domain of VDR (data 
not shown). This same mutation has been previously reported in 2 independent cases of VDDR 
IIA.24-25 The mutation R30X is predicted to result in the absence of functional VDR protein due to 
degradation of the nonsense-bearing transcripts via nonsense-mediated mRNA decay.26-27 
COMMENT 
Despite the different molecular causes of APL and VDDR IIA, there is a major similarity in the 
clinical picture of these 2 autosomal recessive diseases. Both diseases share early onsetwith hair 
shedding during the first year and the frontal to posterior progression of scalp hair loss. 
Examination in the present cases revealed a completely smooth scalp with a few hairs remaining on 
top, a lack of body hair, and sparse eyebrows. Generally, complete absence or almost complete 
absence of a mustache is apparent in patients with APL, while normal eyelashes, a sparse mustache, 
and few hairs in other locations (under the lower lip and on the ear) are seen in patients with VDDR 
IIA. 
The appearance of papules at age 2 to 5 years, their locations (mainly scalp, face, elbows, and 
knees), and the pitting that results from improvement with time and involution of papulesare 
striking. It is of interest that the number and age of onset of papules in affected individuals in this 
study and in previous work9 exhibit interfamilial and intrafamilial variation among family members 
with APL and VDDR IIA or in patients with the same mutation in different families with APL. 
These differences may be due to partial improvement with time, disappearance of lesions with or 
without pitting, late appearance of papules, and/or potential modifying factors. Also of interest is 
the fact that some patients with APL as well as some with VDDR IIA may retain a few hairs on the 
top of scalp for years. The hypopigmented lesions of the scalp seen in many (but not all) patients 
with APL are seen also in some patients with VDDR IIA. The histologic findings in the third 
patient with VDDR IIA of family 4, including the lack of mature hair follicles and presence of 
dermal cysts, are similar to the biopsy findings for patients with APL in previous studies.9-10, 
16 Patients with VDDR IIA share the full range of symptoms of vitamin D deficiency, including 
hypocalcemia, osteomalacia, and rickets. Skeletal abnormalities have been rarely described in 
patients with APL, but the 3 cases reported include a retarded ossification of bone in affected 
individuals manifesting as a decrease in ossification centers in the wrist and hands.12, 28-30 All 
patients with APL in the present study showed normal growth. 
We have identified a novel HR mutation in family 1 and a recurrent mutation in families 2 and 3, all 
with APL. The deletion 177del11 in family 1 represents half of a tandem duplication 22 bp in length 
(the first 11 bp capitalized and italicized; the second 11 bp capitalized only: . . . 
gactccTGGCTTCCCCCTGGCTTCCCCCagggcc . . . ). This sequence contains a long run of 
pyrimidines known as a homocopolymers, which are known to be sites of slippage and mispairing 
of repeated sequences at the replication fork during DNA replication, resulting in a deletion.31-
33 The mRNA transcribed from this allele would be degraded by nonsense-mediated mRNA 
decay26-27 and lead to the absence of functional hairless protein in the homozygous proband. 
In families 2 and 3, we found the recurrent deletion mutation 2147delC, which leads to a frameshift 
and premature termination codon 554 bp downstream in exon 12. This mutation was first identified 
in the homozygous state in 5 Arab-Palestinian families.9 Four of these families lived in the same 
village east of Jerusalem, while the fifth resided approximately 48 km (30 miles) away. Families 2 
and 3 in the present study and the previously reported 5 families resided within 240 km (150 miles) 
of each other. Given the relatively restricted geographical region and the nature of the mutation, it is 
highly likely that 2147delC isa "founder" mutation. 
Finally, in families 4 and 5, we identified 2 previously described nonsense mutations in the ligand-
binding and DNA-binding domains of the VDR, respectively.21, 23-25 While both mutations 
occur within critical functional domains, it is likely that they lead to the degradation of nonsense-
containing transcripts via nonsense-mediated mRNA decay rather than truncated proteins.26-27 
Despite the obvious genetic heterogeneity underlying APL and VDDR IIA, the clinical phenotypes 
with respect to atrichia are essentially identical. In this study, we show clinical and 
histologic support for the argument that the atrichia of patients with VDDR IIA and VDR mutations 
and that of patients with APL and HR mutations is clinically almost indistinguishable, 34 raising 
the possibility of a functional relationship between these 2 proteins. These findings also extend the 
observations made in the hairless 35 and VDR null-mutant 36-37 mouse models, which correspond 
to APL and VDDR IIA, respectively. Interestingly, it has been noted in the VDR null mutant that 
normalization of the mineral imbalance by a diet high in calcium can reverse the bony phenotypes 
but does not correct the alopecia. 38 
Patients with VDDR IIA are treated with intravenous infusion of calcium because they 
characteristically do not respond to even high doses of vitamin D or calcium, which 
distinguishes this form of rickets from VDDR I. Similar to the VDR null mice, this treatment leads 
to correction of mineral and bone abnormalities but not to the restoration of hair growth. 39 
Similarly,  there is no effective treatment for hair regrowth in patients with APL. The parents of the 
patients with VDDR IIA in the present study were able to recognize the new patients in the 
family by the hair loss, which appears prior to the bony abnormalities. At present, molecular 
diagnosis may also contribute to the recognition of new patients. However, it is important to 
recognize the atrichia component in these 2 diseases, which may be mistaken for 
alopeciauniversalis and therefore lead to unnecessary treatment. 
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FIGURES 
 Figure 1. A, C, and E, Clinical presentation of atrichia with papular lesions (APL); B, D, and F, clinical 
presentation of vitamin D–dependent rickets IIA (VDDR IIA). Both conditions cause complete atrichia (A 
and B), sparse eyebrows and eyelashes (C and D), and papular eruptions around and under the eye (C and D) 
and around the knees (E and F). Key to the photographs: A, C, and E, proband from APL family 1, a 21-
year-old woman; B, the first and second probands of VDDR IIA family 4, twin 3-year-old girls; D, the 
proband from VDDR IIA family 5, a 47-year-old man; and F, the third proband of VDDR IIA family 4, a 25-
year-old man. 
 
 
 
 
 
Figure 2. Mutation analysis in family 1. A, Pedigree of the nuclear family: the proband, individual III:2, is 
indicated by a solid circle, and the unaffected carrier parents by half-solid/half-open symbols. B, Sequence 
analysis of exon 2 of the hairless (HR) gene revealed a homozygous 11–base pair (bp) deletion in the 
proband (lower panel, arrow), designated 177del11. The mutation was carried in the heterozygous state in 
both parents (middle panel) compared with the control sequence (upper panel). Note the tandem duplication 
of 11 bp (TGGCTTCCCCC/TGGCTTCCCCC) and the absence of 1 block of 11 bp in individual III:2. 
